Posted 2024-11-13
The 2024 US presidential election outcome signals potential shifts in the transatlantic pharmaceutical landscape. Key points to watch: Trade Policy Shifts Proposed tariffs of up to 10% on imports with up to 60% on Chinese go (...)
Read morePosted 2024-10-17
The European Union has just ushered in a new era with a transformative regulation on Substances of Human Origin (SoHO), effectively modernizing a framework that had been in place for two decades! This sweeping reform is set (...)
Read morePosted 2024-10-09
In today's rapidly evolving pharmaceutical landscape, artificial intelligence (AI) is not just a buzzword - it's a catalyst for transformative change across the entire medicinal product lifecycle. As we look to the future, i (...)
Read more